Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

The latest consensus “guidelines” outlining revised Classification Criteria for
antiphospholipid syndrome (APS) has just been published. 1 The aim of this publication was …

Background Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of
lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti‐β2 glycoprotein I (aβ2GPI) …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL) …

A molecular mimicry between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) and human proteins supports the possibility that autoimmunity takes place during …

Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …

Background The added value of antiphosphatidylserine/prothrombin antibodies (aPS/PT) in
the diagnostic workup of antiphospholipid syndrome (APS) is unclear. Currently, diagnosis …

Context.—Misdiagnosis of antiphospholipid syndrome can occur owing to the wide diversity
of antiphospholipid (aPL) assays and a lack of international calibrators and harmonized …

Objectives This study aimed to assess the performance of cardiovascular risk (CVR)
prediction models reported by European Alliance of Associations for Rheumatology and …